HOME >> BIOLOGY >> NEWS
Professor calls for a new branch of learning

Nanotechnology, the 'science of small things' is set to bring huge advantages in engineering, electronics, medicine and IT-- but the potential threats to health that widespread use of nanoparticles could bring need to be scrutinised, says a University of Edinburgh expert in this month's edition of Occupational and Environmental Medicine.

Professor Ken Donaldson, a lung toxicology expert and Professor of Respiratory Medicine at the University, calls for a new discipline--nanotoxicology-- to be built up, to address knowledge gaps and to help develop a safe nanotechnology. He wants guidelines to be developed to test all materials in the nanoscale where human health could be involved.

Professor Donaldson says: "We believe that efforts to untangle science and science fiction regarding the risks from nanotechnology are needed and that a focus on the potential harmful effects of nanoparticles is both timely and necessary. The importance of nanotechnology to the economy and to our future wellbeing is beyond debate, but its potential adverse impacts need to be studied along the same lines. A discipline of nanotoxicology would make an important contribution to the development of a sustainable and safe nanotechnology .

He added: "Our current knowledge of the toxicology of nanoparticles and nanotubes (tiny carbon tubes) is poor but suggests that nanoparticles may be able to have undesirable effects at their point of entry into the body, for example, the lungs, and might also be able to affect other organs. Nanoparticles in food may cross into the gut lymphatic system and so reach other organs more easily than larger particles do. Inhaled nanoparticles have been reported to travel from nasal nerves to the brain, a phenomenon seen with some viruses similar in size to nanoparticles."

Nanoparticles, materials the size of millionths of a millimetre, are already present in large numbers in the air from natural sources and from vehicle exhaust emissio
'"/>

Contact: Linda Menzies
linda.menzies@ed.ac.uk
44-131-650-6382
University of Edinburgh
30-Aug-2004


Page: 1 2

Related biology news :

1. Professor and student among tops in technology at UH
2. Professor publishes book on historic mosquito wars
3. Professor uses satellites to protect Amazon forests, global climate
4. Sarah Billington and Alexandria Boehm named Clare Boothe Luce Assistant Professors
5. Professor develops strategies to control exotic plant species
6. LSU Professor Emeritus wins 2001 National Wetlands Award
7. Professor says college athletic departments must pay more attention to eating disorders
8. Professor Will Connect With Students Live From China Dinosaur Site
9. Wistar Institute Professor Named First Koprowski Professor
10. Virginia Tech Fisheries Professor Works To Conserve Mussels
11. Professor Authors Complete Guide To Fungi

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Professor calls for new branch learning

(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
(Date:12/17/2014)... Xeno Diagnostics has again received ... recent COLA inspection. Xeno has met all criteria ... accreditation organization. Accreditation is earned only by laboratories ... operations, demonstrate continued accuracy in the performance of ... survey. , While the Laboratory Excellence ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a primary commercial focus on ... has been granted a Type C meeting with the ... meeting will be held in February 2015.  During this ...
(Date:12/15/2014)... DIEGO , Dec. 15, 2014 ... three-dimensional biology company focused on delivering breakthrough 3D ... the industry and collaborators of its exVive3D TM ... made widely available in full commercial release on ... the field, resulting in several awards for innovation. ...
(Date:12/13/2014)... and Virgin Unite Canada, the non-profit foundation of the Virgin ... Canadian entrepreneurs tackling social and environmental challenges. Today, Sir ... Centre to announce the new partnership, which includes the development ... $1 million in seed capital provided by Virgin Unite Canada ... Foundation, founded by Alison Lawton . ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3
Cached News: